Who we are
Meet our team.
We have assembled a team of experienced scientists and industry pioneers, including cancer and diagnostic experts and accomplished company builders who are passionate about changing the outlook of a cancer diagnosis.
Our investors include Third Rock Ventures, Section 32, Casdin Capital, Biomatics Capital, BlueCross BlueShield Venture Partners, Invus and others – leading investors in the fields of cancer diagnosis and treatment.
Christoph Lengauer, Ph.D. Co-Founder and Chief Innovation Officer; Partner, Third Rock Ventures View Bio ›
Nickolas Papadopoulos, Ph.D. Professor of Oncology and Pathology at the Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University View Bio ›
Kenneth W. Kinzler, Ph.D. Professor of Oncology, Co-Director of the Ludwig Institute at the Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University View Bio ›
Bert Vogelstein, M.D. Clayton Professor of Oncology and Pathology and Co-Director of the Ludwig Institute at the Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University; Investigator, Howard Hughes Medical Institute View Bio ›
Nickolas Papadopoulos, Ph.D. Professor of Oncology and Pathology at the Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University View Bio ›
Kenneth W. Kinzler, Ph.D. Professor of Oncology, Co-Director of the Ludwig Institute at the Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University View Bio › Christoph Lengauer, Ph.D. Co-Founder and Chief Innovation Officer; Partner, Third Rock Ventures View Bio ›
